Products
-
- BBB DamageCell Death and ApoptosisNeuroinflammationNeuronal Damage and RepairOxidative StressVascular Mechanisms
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Human DLL1 ELISA Kit (AC3268)
Cat.#: ASET-1857
Specifications
Description Human DLL1 ELISA Kit allows for the in vitro quantitative determination of human DLL1 concentrations in serum, plasma, tissue homogenates, and other biological fluids. The kit employs the sandwich enzyme immunoassay technique. Size 96T Sample Type Serum, plasma, tissue homogenates, and other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 18.75 pg/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 31.25-2000 pg/mL Assay Time 4h 30m Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-2470 Human MAS1L ELISA Kit (AC3881) Quantitative inquiry ASET-1805 Mouse Adenosine A1 Receptor ELISA Kit (AC3216) Quantitative inquiry ASET-2167 Rat AHSG ELISA Kit (AC3578) Quantitative inquiry ASET-2089 Chicken CNTF ELISA Kit (AC3500) Quantitative inquiry ASET-1329 Human MC1-R ELISA Kit (AC2740) Quantitative inquiry ASET-1027 Mouse Gpi ELISA Kit (AC2438) Quantitative inquiry ASET-1264 Rat TSH beta ELISA Kit (AC2675) Quantitative inquiry ASET-1968 Mouse EGR3 ELISA Kit (AC3379) Quantitative inquiry ASET-1383 Human EPHA10 ELISA Kit (AC2794) Quantitative inquiry ASET-1326 Human MEF2A ELISA Kit (AC2737) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
We are committed to accelerating progress in stroke research and drug development.
Copyright © Ace Therapeutics. All rights reserved.0Inquiry Basket